General information

Announcements(0)

Greetings from the Chair

Overview

Web abstract

Best Student Presentation Award

Selected programs of presentations in English

Registration

Registration (Non-presenters under 4th year underg

Information for Participants

Information for Presenters and Chairs

Banquet

Luncheon Seminar & Career Design Seminar

General information 2

Abstract Submission (Oral/Poster Presentation) for

Abstract Submission (Oral/Poster Presentation)

Timetable

Fri. Mar 29, 2024

Sat. Mar 30, 2024

Sun. Mar 31, 2024

Program

Sessions

Search presentations

20230323085903895_en.png

app_icon.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br><br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Development of large-scale analysis technology for RNA-molecular interactions that contributes to RNA-targeted drug discovery

In recent years, mid-size drugs such as peptides and nucleic acids have attracted attention as a new modality that combines the advantages of both small molecule drugs and biopharmaceuticals. Mid-size drugs have the characteristics of being able to target intracellular targets, have high target specificity, and can be chemically synthesized, and is expected to be a next-generation drug that will play a role in expanding drug discovery targets. <br />  With the aim of creating mid-size drugs, a variety of research is underway, focusing on a wide range of molecular types, including peptides, nucleic acids, sugar chains, and artificial chimeric molecules. To efficiently synthesize and highly functionalize these molecules, next-generation molecular and analytical technologies suitable for molecular species, new functionalization concepts and fusion research between molecular types are required. In this symposium, "Frontiers of mid-size drug discovery research—next generation molecular technology that contributes to mid-size drug discovery—", five speakers with diverse molecular technologies contributing to mid-size drug discovery will give lectures on some of the latest research.

Frontiers of mid-size drug discovery research —next generation molecular technology that contributes to mid-size drug discovery—

The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

Presentation Information

[S19-1]Development of large-scale analysis technology for RNA-molecular interactions that contributes to RNA-targeted drug discovery

Password required to view